13F-HR filed by CAPTRUST FINANCIAL ADVISORS
CAPTRUST FINANCIAL ADVISORS filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-15, with 2,506 holding rows worth $44,819,019,584.
- Accession
- 0001062993-25-014473
- Filer
- CIK 1512024
- Filed
- 2025-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 2,506 entries on the cover page, a total value of $44,819,019,584 stated on the cover page (in dollars after the unit check, H1), rows summing to $44,819,019,584 with VALUE read as dollars as filed, 13F file number 028-14079. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 13,566 | $8,292 | dollars as filed | |
| BIOAFFINITY TECHNOLOGIES INC | 09076W109 | COM | 27,885 | $8,009 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 10,998 | $7,851 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 10,494 | $7,695 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 10,000 | $3,380 | dollars as filed | |
| ACLARION INC | 655187110 | *W EXP 04/21/202 | 78,400 | $2,815 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001062993-25-014473 | this filing | 2025-08-15 | acceptance time not in the bulk data set |